Acquisitions by big pharma companies since 2000
Number of companies
Total sum of acquisitions in CHF (bn)
Roche
49
84.4
Novartis
45
120.7
Pfizer
30
373.9
Merck SD
28
69.5
GSK
21
21.5
Sanofi
22
130.6
Johnson & Johnson
29
60.1
Gilead
16
30.3
Eli Lilly
15
27.4
AstraZeneca
12
11.7
Takeda
10
108.7
Bayer
14
80
Teva Pharmaceutical
8
52.1
Biogen Idec
6
1.2
Abbvie
5
88.5
Novo Nordisk
5
1.4
Main acquisitions made by the 16 major companies that have approved a drug in Switzerland over the last two years.